Fig. 1

Schematic overview of study design. Non-steroidal AI: non-steroidal aromatase-inhibitor, either letrozole or anastrozole (at the discretion of the treating physician). CDK4/6 inhibitor: type of CDK4/6 inhibitor according to physician’s choice and reimbursement policies